Last Updated: May 2, 2026

CUPRIC SULFATE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Cupric Sulfate, and when can generic versions of Cupric Sulfate launch?

Cupric Sulfate is a drug marketed by Abraxis Pharm, Am Regent, and Apotex Corp. and is included in three NDAs.

The generic ingredient in CUPRIC SULFATE is cupric sulfate. Additional details are available on the cupric sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cupric Sulfate

A generic version of CUPRIC SULFATE was approved as cupric sulfate by AM REGENT on December 16^th, 2022.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CUPRIC SULFATE?
What are the global sales for CUPRIC SULFATE?
What is Average Wholesale Price for CUPRIC SULFATE?

Summary for CUPRIC SULFATE

US Patents:	0
Applicants:	3
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	100
Patent Applications:	2,817
DailyMed Link:	CUPRIC SULFATE at DailyMed

Drug patent expirations by year for CUPRIC SULFATE

US Patents and Regulatory Information for CUPRIC SULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abraxis Pharm	CUPRIC SULFATE	cupric sulfate	INJECTABLE;INJECTION	019350-001	May 5, 1987		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Am Regent	CUPRIC SULFATE	cupric sulfate	INJECTABLE;INJECTION	216324-001	Dec 16, 2022		RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Apotex Corp	CUPRIC SULFATE	cupric sulfate	INJECTABLE;INJECTION	218745-001	Aug 19, 2024		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.